309 related articles for article (PubMed ID: 21513711)
1. Contrasting effects of TNF and anti-TNF on the activation of effector T cells and regulatory T cells in autoimmunity.
Chen X; Oppenheim JJ
FEBS Lett; 2011 Dec; 585(23):3611-8. PubMed ID: 21513711
[TBL] [Abstract][Full Text] [Related]
2. The Significance of Tumor Necrosis Factor Receptor Type II in CD8
Ye LL; Wei XS; Zhang M; Niu YR; Zhou Q
Front Immunol; 2018; 9():583. PubMed ID: 29623079
[TBL] [Abstract][Full Text] [Related]
3. In vitro generated Th17 cells support the expansion and phenotypic stability of CD4(+)Foxp3(+) regulatory T cells in vivo.
Zhou Q; Hu Y; Howard OM; Oppenheim JJ; Chen X
Cytokine; 2014 Jan; 65(1):56-64. PubMed ID: 24080164
[TBL] [Abstract][Full Text] [Related]
4. TNF-alpha: an activator of CD4+FoxP3+TNFR2+ regulatory T cells.
Chen X; Oppenheim JJ
Curr Dir Autoimmun; 2010; 11():119-34. PubMed ID: 20173391
[TBL] [Abstract][Full Text] [Related]
5. Interaction of TNF with TNF receptor type 2 promotes expansion and function of mouse CD4+CD25+ T regulatory cells.
Chen X; Bäumel M; Männel DN; Howard OM; Oppenheim JJ
J Immunol; 2007 Jul; 179(1):154-61. PubMed ID: 17579033
[TBL] [Abstract][Full Text] [Related]
6. TNFR2 is critical for the stabilization of the CD4+Foxp3+ regulatory T. cell phenotype in the inflammatory environment.
Chen X; Wu X; Zhou Q; Howard OM; Netea MG; Oppenheim JJ
J Immunol; 2013 Feb; 190(3):1076-84. PubMed ID: 23277487
[TBL] [Abstract][Full Text] [Related]
7. TNF activates a NF-kappaB-regulated cellular program in human CD45RA- regulatory T cells that modulates their suppressive function.
Nagar M; Jacob-Hirsch J; Vernitsky H; Berkun Y; Ben-Horin S; Amariglio N; Bank I; Kloog Y; Rechavi G; Goldstein I
J Immunol; 2010 Apr; 184(7):3570-81. PubMed ID: 20181891
[TBL] [Abstract][Full Text] [Related]
8. Modulation of Regulatory T Cell Activity by TNF Receptor Type II-Targeting Pharmacological Agents.
Zou H; Li R; Hu H; Hu Y; Chen X
Front Immunol; 2018; 9():594. PubMed ID: 29632537
[TBL] [Abstract][Full Text] [Related]
9. Continuum model of T-cell avidity: Understanding autoreactive and regulatory T-cell responses in type 1 diabetes.
Jaberi-Douraki M; Pietropaolo M; Khadra A
J Theor Biol; 2015 Oct; 383():93-105. PubMed ID: 26271890
[TBL] [Abstract][Full Text] [Related]
10. Control of GVHD by regulatory T cells depends on TNF produced by T cells and TNFR2 expressed by regulatory T cells.
Leclerc M; Naserian S; Pilon C; Thiolat A; Martin GH; Pouchy C; Dominique C; Belkacemi Y; Charlotte F; Maury S; Salomon BL; Cohen JL
Blood; 2016 Sep; 128(12):1651-9. PubMed ID: 27506541
[TBL] [Abstract][Full Text] [Related]
11. Regulatory T cells express Tumor Necrosis Factor Receptor 2 with the highest intensity among CD4
Ghods A; Mehdipour F; Shariat M; Talei AR; Ghaderi A
Mol Immunol; 2021 Sep; 137():52-56. PubMed ID: 34214829
[TBL] [Abstract][Full Text] [Related]
12. Pathogenic T cells have a paradoxical protective effect in murine autoimmune diabetes by boosting Tregs.
Grinberg-Bleyer Y; Saadoun D; Baeyens A; Billiard F; Goldstein JD; Grégoire S; Martin GH; Elhage R; Derian N; Carpentier W; Marodon G; Klatzmann D; Piaggio E; Salomon BL
J Clin Invest; 2010 Dec; 120(12):4558-68. PubMed ID: 21099113
[TBL] [Abstract][Full Text] [Related]
13. Increased Regulatory T Cells in Peripheral Blood of Acute Myeloid Leukemia Patients Rely on Tumor Necrosis Factor (TNF)-α-TNF Receptor-2 Pathway.
Wang M; Zhang C; Tian T; Zhang T; Wang R; Han F; Zhong C; Hua M; Ma D
Front Immunol; 2018; 9():1274. PubMed ID: 29922294
[TBL] [Abstract][Full Text] [Related]
14. The effects of TNF-α/TNFR2 in regulatory T cells on the microenvironment and progression of gastric cancer.
Qu Y; Wang X; Bai S; Niu L; Zhao G; Yao Y; Li B; Li H
Int J Cancer; 2022 Apr; 150(8):1373-1391. PubMed ID: 34766338
[TBL] [Abstract][Full Text] [Related]
15. TNF-TNFR2 Signal Plays a Decisive Role in the Activation of CD4
Islam MS; Yang Y; Chen X
Adv Exp Med Biol; 2021; 1278():257-272. PubMed ID: 33523452
[TBL] [Abstract][Full Text] [Related]
16. Interplay between mTOR and STAT5 signaling modulates the balance between regulatory and effective T cells.
Shan J; Feng L; Sun G; Chen P; Zhou Y; Xia M; Li H; Li Y
Immunobiology; 2015 Apr; 220(4):510-7. PubMed ID: 25468562
[TBL] [Abstract][Full Text] [Related]
17. Insufficient secretion of IL-10 by Tregs compromised its control on over-activated CD4+ T effector cells in newly diagnosed adult immune thrombocytopenia patients.
Li F; Ji L; Wang W; Hua F; Zhan Y; Zou S; Yuan L; Ke Y; Min Z; Song D; Sun L; Chen H; Cheng Y
Immunol Res; 2015 Mar; 61(3):269-80. PubMed ID: 25550089
[TBL] [Abstract][Full Text] [Related]
18. Splicing factor SRSF1 controls distinct molecular programs in regulatory and effector T cells implicated in systemic autoimmune disease.
Cassidy MF; Herbert ZT; Moulton VR
Mol Immunol; 2022 Jan; 141():94-103. PubMed ID: 34839165
[TBL] [Abstract][Full Text] [Related]
19. Differential role of TNFR1 and TNFR2 in the development of imiquimod-induced mouse psoriasis.
Chen S; Lin Z; Xi L; Zheng Y; Zhou Q; Chen X
J Leukoc Biol; 2021 Dec; 110(6):1047-1055. PubMed ID: 34494306
[TBL] [Abstract][Full Text] [Related]
20. Tumor Necrosis Factor α and Regulatory T Cells in Oncoimmunology.
Salomon BL; Leclerc M; Tosello J; Ronin E; Piaggio E; Cohen JL
Front Immunol; 2018; 9():444. PubMed ID: 29593717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
